Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease

Journal of Neurochemistry

Volumn 83, Issue 2, 2002, Pages 320-330

  Faucheux, Baptiste A ^a   Martin, Marie Elise ^b   Beaumont, Carole ^b   Hunot, Stéphane ^a   Hauw, Jean Jacques ^a   Agid, Yves ^a   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Ferritin; Iron; Iron regulatory proteins; Melanized neurones; Mesencephalon; Parkinson's disease

Indexed keywords

FERRITIN; IRON; IRON REGULATORY FACTOR; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MESSENGER RNA; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOPSY; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUMAN TISSUE; IRON RESPONSIVE ELEMENT; MALE; MESENCEPHALON; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RNA TRANSLATION; SUBSTANTIA NIGRA; TRANSCRIPTION REGULATION;

AGED; AGED, 80 AND OVER; CELL COUNT; CYTOPLASM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FERRITINS; HUMANS; IN SITU HYBRIDIZATION; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MALE; MESENCEPHALON; MIDDLE AGED; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN SUBUNITS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SUBSTANTIA NIGRA; UP-REGULATION;

PARKINSONIA;

EID: 0036798434     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01118.x     Document Type: Article

References (53)

1. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P. and Halliwell B. (1997a) A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69, 1326-1329.
2. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P. and Halliwell B. (1997b) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxy-guanine levels in substantia nigra. J. Neurochem. 69, 1196-1203.
3. Butt J., Kim H. Y., Basilion J. P., Cohen S., Iwai K., Philpott C. C., Altschul S., Klausner R. D. and Rouault T. A. (1996) Differences in the RNA binding sites of iron regulatory proteins and potential target diversity. Proc. Natl Acad. Sci. USA 93, 4345-4349.
4. Connor J. R. and Menzies S. L. (1995) Cellular management of iron in the brain. J. Neurol. Sci. 134, 33-44.
5. Connor J. R., Snyder B. S., Arosio P., Loeffler D. A. and LeWitt P. (1995) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65, 717-724.
6. Dexter D. T., Wells F. R., Lees A. J., Agid F., Agid Y., Jenner P. and Marsden C. D. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830-1836.
7. Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P. and Marsden D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953-1975.
8. Drapier J. C. and Bouton C. (1996) Modulation by nitric oxide of metalloprotein regulatory activities. Bioessays 18, 549-556.
9. Earle K. M. (1968) Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J. Neuropathol. Exp. Neurol. 27, 1-14.
10. Faucheux B. A., Bonnet A. M., Agid Y. and Hirsch E. C. (1999) Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353, 981-982.
11. Foley P. and Riederer P. (2000) Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. J. Neurol. 247, II82-II94.
12. Foster O. J. F., Kingsbury A., Dexter D. T., Blunt S., Lightman S. L., Marsden C. D. and Jenner P. (1991) Ferritin mRNA expression in rat brain: effects of 6-hydroxydopamine lesions and levodopa administration. Soc. Neurosci. Abstracts 17, 1288.
13. Good P. F., Olanow C. W. and Perl D. P. (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease: a LAMMA study. Brain Res. 593, 343-346.
14. Good P. F., Hsu A., Werner P., Perl D. P. and Olanow C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342.
15. Gorell J. M., Ordidge R. J., Brown G. G., Deniau J. C., Buderer N. M. and Helpern J. A. (1995) Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 45, 1138-1143.
16. Goto K., Mochizuki H., Imai H., Akiyama H. and Mizuno Y. (1996) An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Brain Res. 724, 125-128.
17. Graybiel A. M. and Ragsdale C. W. (1978) Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase stain. Proc. Natl Acad. Sci. USA 75, 1723-1726.
18. Guo B., Brown F. M., Phillips J. D., Yu Y. and Leibold E. A. (1995) Characterization and expression of iron regulatory protein 2 (IRP2). Presence of multiple IRP2 transcripts regulated by intracellular iron levels. J. Biol. Chem. 270, 16529-16535.
19. Hallgren B. and Sourander P. (1958) The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3, 41-51.
20. Harrison P. M. and Arosio P. (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161-203.
21. He Y., Thong P. S. P., Lee T., Leong S. K., Shi C. Y., Wong P. T. H., Yuan S. Y. and Watt F. (1996) Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study. Brain Res. 735, 149-153.
22. Henderson B. R., Seiser C. and Kühn L. C. (1993) Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements. J. Biol. Chem. 268, 27327-27334.
23. Hentze M. W. and Kühn L. C. (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl Acad. Sci. USA 93, 8175-8182.
24. Hirsch E. C. and Faucheux B. A. (1998) Iron metabolism and Parkinson's disease. Mov. Disord. 13, 39-45.
25. Hirsch E., Graybiel A. M. and Agid Y. A. (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334, 345-348.
26. Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F. and Agid Y. (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56, 446-451.
27. Hirsch E. C., Hunot S., Damier P. and Faucheux B. (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44, S115-S120.
28. Hoehn M. M. and Yahr M. D. (1967) Parkinsonism: onset, progression and mortality. Neurology 17, 427-442.
29. Hu J. and Connor J. R. (1996) Demonstration and characterization of the iron regulatory protein in human brain. J. Neurochem. 67, 838-844.
30. Hunot S., Boissière F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y. and Hirsch E. C. (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72, 355-363.
31. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debré P., Agid Y., Dugas B. and Hirsch E. C. (1999) FcεRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells. J. Neurosci. 19, 3340-3347.
32. Jellinger K., Paulus W., Grundke-Iqbal I., Riederer P. and Youdim M. B. H. (1990) Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Transm. (Park Dis. Dementia Section) 2, 327-340.
33. Jellinger K., Kienzl E., Rumpelmair G., Riederer P., Stachelberger H., Ben-Shachar D. and Youdim M. B. H. (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis. J Neurochem. 59, 1168-1171.
34. Jenner P. and Olanow C. W. (1998) Understanding cell death in Parkinson's disease. Ann. Neurol. 44, S72-S84.
35. Labarca C. and Paigen K. (1980) A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102, 344-352.
36. Leibold E. A. and Munro H. N. (1988) Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl Acad. Sci. USA 85, 2171-2175.
37. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., McAuliffe W. G., Dawson V. L., Dawson T. M. and Przedborski S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5, 1403-1409.
38. Lin E., Graziano J. H. and Freyers G. A. (2001) Regulation of the 75-kDa subunit of mitochondrial Complex I by iron. J. Biol. Chem. 276, 27685-27692.
39. Loeffler D. A., Connor J. R., Juneau P. L., Snyder B. S., Kanaley L., DeMaggio A. J., Nguyen H., Brickman C. M. and LeWitt P. A. (1995) Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J. Neurochem. 65, 710-716.
40. Luzzago A., Arosio P., Iacobello C., Ruggeri G., Capucci L., Brocchi E., De Simone F., Gamba D., Gabri E., Levi S. and Albertinin A. (1986) Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. Biochim. Biophys. Acta 872, 61-71.
41. Mann V. M., Cooper J. M., Daniel S. E., Srai K., Jenner P., Marsden C. D. and Schapira A. H. V. (1994) Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann. Neurol. 36, 876-881.
42. Martin M. E., Fargion S., Brissot P., Pellat B. and Beaumont C. (1998) A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndrome. Blood 91, 319-323.
43. Mochizuki H., Imai H., Endo K., Yokomizo K., Murata Y., Hattori N. and Mizuno Y. (1994) Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci. Lett. 168, 251-253.
44. Muckenthaler M., Gray N. K. and Hentze M. W. (1998) IRP-1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex eIF4F. Mol. Cell 2, 383-388.
45. Mulero V. and Brock J. H. (1999) Regulation of iron metabolism in murine J774 macrophages: role of nitric oxide-dependent and -independent pathways following activation with gamma interferon and lipopolysaccharide. Blood 94, 2383-2389.
46. Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J. M., Farer M. and Wolozin B. (2000) The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20, 6048-6054.
47. Pinero D. J. and Connor J. R. (2000) Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzeimer's diseased brains. Cell. Mol. Biol. 46, 761-776.
48. Ponka P., Beaumont C. and Richardson D. R. (1998) Function and regulation of transferrin and ferritin. Semin. Hematol. 35, 35-54.
49. Riederer P., Dirr A., Goetz M., Sofic E., Jellinger K. and Youdim M. B. H. (1992) Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease. Ann. Neurol. 32, S101-S104.
50. Smith M. A., Harris P. L. R., Sayre L. M. and Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 94, 9866-9868.
51. Smith M. A., Wehr K., Harris P. L. R., Siedlak S. L., Connor J. R. and Perry G. (1998) Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res. 788, 232-236.
52. Vila M., Levy R., Herrero M. T., Ruberg M., Faucheux B., Obeso J. A., Agid Y. and Hirsch E. C. (1997) Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J. Neurosci. 17, 765-773.
53. Zecca L., Gallorini M., Schünemann V., Trautwein A. X., Gerlach M., Riederer P., Vezzoni P. and Tampellini D. (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J. Neurochem. 76, 1766-1773.